Abstract
Data are scarce on the impact of vertebral fractures (VFX) on utility. The objective of this study was to assess the impact of prevalent and incident VFX on utility in both a patient-based and population-based sample. Data from the Multiple Outcomes of Raloxifene Evaluation (MORE) study (n = 550 for prevalent VFX and n = 174 for incident VFX) and the European Prospective Osteoporosis Study (EPOS) (n = 236) were used. Utility was assessed by the index score of the EQ-5D. In the MORE study, highly statistically significant associations were found between utility and the presence of prevalent VFX (p < 0.001), number of prevalent VFX (p < 0.001), severity of prevalent VFX (p < 0.001), the combination of number and severity of prevalent VFX (p = 0.001) and location of prevalent VFX (p = 0.019). The mean utility was significantly lower among women who suffered an incident VFX (utility = 0.67) than among women who did not (utility = 0.77) (p = 0.005), although utility loss was not significantly different between the two groups (p = 0.142). In EPOS, the combination of number and severity of incident VFX was significantly related to utility (p = 0.030). In conclusion, utility is lower among persons with prevalent and incident VFX, especially in a patient-based sample. Utility loss was not significantly different between women without and with incident VFX.
Similar content being viewed by others
Abbreviations
- VFX:
-
Vertebral fractures
- MORE study:
-
Multiple Outcomes of Raloxifene Study
- EPOS:
-
European Prospective Osteoporosis Study
- EVOS:
-
European Vertebral Osteoporosis Study
- BMD:
-
Bone mineral density
- QALY:
-
Quality-adjusted life years
- SQ:
-
Semi-quantitative
- BSQ:
-
Binary semi-quantitative
- QM:
-
Quantitative morphometric
- BMI:
-
Body mass index
References
Kanis, J. A., Johnell, O., Oden, A., Borgstrom, F., Zethraeus, N., de Laet, C., et al. (2004). The risk and burden of vertebral fractures in Sweden. Osteoporosis International, 15, 20–26.
Hasserius, R., Redlund-Johnell, I., Mellstrom, D., Johansson, C., Nilsson, B. E., & Johnell, O. (2001). Vertebral deformation in urban Swedish men and women – Prevalence based on 797 subjects. Acta Orthopaedica Scandinavica, 72, 273–278.
Pluijm, S. M., Tromp, A. M., Smit, J. H., Deeg, D. J., & Lips, P. (2000). Consequences of vertebral deformities in older men and women. Journal of Bone and Mineral Research, 15, 1564–1572.
Lau, E. M. C., Woo, J., Chan, H., Chan, M. K. F., Griffith, J., Chan, Y. H., et al. (1998). The health consequences of vertebral deformity in elderly Chinese men and women. Calcified Tissue International, 63, 1–4.
Jones, G., White, C., Nguyen, T., Sambrook, P. N., Kelly, P. J., & Eisman, J. A. (1996). Prevalent vertebral deformities: Relationship to bone mineral density and spinal osteophytosis in elderly men and women. Osteoporosis International, 6, 233–239.
Melton, L. J. III, Lane, A. W., Cooper, C., Eastell, R., O’Fallon, W. M., & Riggs, B. L. (1993). Prevalence and incidence of vertebral deformities. Osteoporosis International, 3, 113–119.
Silverman, S. L. (1992). The clinical consequences of vertebral compression fracture. Bone, 13(Suppl 2), S27–S31.
O’Neill, T. W., Felsenberg, D., Varlow, J., Cooper, C., Kanis, J. A., Silman, A. J., et al. (1996). The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study. Journal of Bone and Mineral Research, 11, 1010–1018.
Felsenberg, D., Silman, A. J., Lunt, M., Armbrecht, G., Ismail, A. A., Finn, J. D., et al. (2002). Incidence of vertebral fracture in Europe: Results from the European Prospective Osteoporosis Study (EPOS). Journal of Bone and Mineral Research, 17, 716–724.
Oleksik, A. M., Ewing, S., Shen, W., van Schoor, N. M., & Lips, P. (2005). Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporosis International, 16, 861–870.
van Schoor, N. M., Smit, J. H., Twisk, J. W. R., & Lips, P. (2005). Impact of vertebral deformities, osteoarthritis, and other chronic diseases on quality of life: A population-based study. Osteoporosis International, 16, 749–756.
Cockerill, W., Lunt, M., Silman, A. J., Cooper, C., Lips, P., Bhalla, A. K., et al. (2004). Health-related quality of life and radiographic vertebral fracture. Osteoporosis International, 15, 113–119.
Adachi, J. D., Loannidis, G., Berger, C., Joseph, L., Papaioannou, A., Pickard, L., et al. (2001). The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporosis International, 12, 903–908.
Oleksik, A., Lips, P., Dawson, A., Minshall, M. E., Shen, W., Cooper, C., et al. (2000). Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. Journal of Bone and Mineral Research, 15, 1384–1392.
Lips, P., Cooper, C., Agnusdei, D., Caulin, F., Egger, P., Johnell, O., et al. (1999). Quality of life in patients with vertebral fractures. Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteoporosis International, 10, 150–160.
Hall, S. E., Criddle, R. A., Comito, T. L., & Prince, R. L. (1999). A case–control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporosis International, 9, 508–515.
Johnell, O., Kanis, J., deLaet, C., Jonsson, B., Zethraeus, N., & Oden, A. (2002). Sequential changes in quality of life after osteoporotic fractures. Osteoporosis International, 13, S70.
Tosteson, A. N., Gabriel, S. E., Grove, M. R., Moncur, M. M., Kneeland, T. S., & Melton, L. J. (2001). Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporosis International, 12, 1042–1049.
Gabriel, S. E., Kneeland, T. S., Melton, L. J., Moncur, M. M., Ettinger, B., & Tosteson, A. N. (1999). Health-related quality of life in economic evaluations for osteoporosis: Whose values should we use? Medical Decision Making, 19, 141–148.
Lips, P., & Van Schoor, N. M. (2005). Quality of life in patients with osteoporosis. Osteoporosis International, 16, 749–756.
Brazier, J. E., Green, C., & Kanis, J. A. (2002). A systematic review of health state utility values for osteoporosis-related conditions. Osteoporosis International, 13, 768–776.
Lunt, M., Ismail, A. A., Felsenberg, D., Cooper, C., Kanis, J. A., Reeve, J., et al. (2002). Defining incident vertebral deformities in population studies: A comparison of morphometric criteria. Osteoporosis International, 13, 809–815.
McCloskey, E. V., Spector, T. D., Eyres, K. S., Fern, E. D., Orourke, N., Vasikaran, S., et al. (1993). The assessment of vertebral deformity – A method for use in population studies and clinical-trials. Osteoporosis International, 3, 138–147.
Brooks, R., Rabin, R., & de Charro, F. (Eds.) (2003). The measurement and valuation of health status using EQ-5D: A European perspective. Kluwer Academic Publishers.
Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35, 1095–1108.
Cockerill, W., Ismail, A. A., Cooper, C., Matthis, C., Raspe, H., Silman, A. J., et al. (2000). Does location of vertebral deformity within the spine influence back pain and disability? Annals of the Rheumatic Diseases, 59, 368–371.
Acknowledgements
Natasja van Schoor was funded by an unconditional grant from Wyeth Research, Collegeville, Pennsylvania. Furthermore, we would like to acknowledge the investigators and participants of the MORE study and EPOS. MORE study: Eli Lilly and Company provided funding for the Multiple Outcomes of Raloxifene Evaluation Trial. These data were presented in part at the Fifth European Congress on Clinical and Economical Aspects of Osteoporosis and Osteoarthritis in 2005. The complete list of all investigators in the MORE study was previously published in: Ettinger B, Black DM et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999; 282, 637–645. Epos: Principal Investigators: Prague (Czech Republic) J Stepan; Berlin (Germany) D Felsenberg; Lubeck (Germany) H Raspe; Budapest (Hungary) C Kiss, G Poor; Piestany (Slovakia) P Masaryk; Oviedo (Spain) JB Cannata, M Naves; Malmo (Sweden) O Johnell; Aberdeen (UK) DM Reid; Bath (UK) A Bhalla; Cambridge (UK) C Todd; Harrow (UK) J Reeve; Sheffield (UK) R Eastell; Truro (UK) AD Woolf. EPOS was financially supported by a European Union Concerted Action Grants under Biomed-1 (BMH 1CT 931448 and 920182), and also EU grants C1PDCT925102, ERBC1PDCT 930105 and 940229. The central coordination was also supported by the UK Arthritis Research Campaign, the Medical Research Council (G9321536), and the European Foundation for Osteoporosis and Bone Disease. Also supported by a grant from Eli Lilly and Company. The EU’s PECO program linked to BIOMED 1 funded in part the participation of the Budapest, Prague and Piestany centers. Data collection in Cambridge was supported by a HSR grant from the Anglia and Oxford region. The central X-ray evaluation was sponsored by the Bundesministerium fur Forschung and Technologie, Germany.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van Schoor, N.M., Ewing, S.K., O’Neill, T.W. et al. Impact of prevalent and incident vertebral fractures on utility: results from a patient-based and a population-based sample. Qual Life Res 17, 159–167 (2008). https://doi.org/10.1007/s11136-007-9287-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-007-9287-0